Doctor profile · Federal record
Dr. Matthew Reichert, M.D.
Pulmonary Disease Physician (CMS: Pulmonary Disease) · Internal Medicine Physician · Critical Care Medicine (Internal Medicine) Physician · Sleep Medicine (Internal Medicine) Physician · Knoxville, TN
- NPI 1477684405
- Accepts Medicare
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 9 locations across 1 states.
- Primary practice
-
6473 Kingston Pike
Knoxville, TN 379194832
(865) 588-8831
fax (865) 588-8841 - Mailing address
-
Po Box 207830
Dallas, TX 753204670
Tennessee — 8 locations
- Additional location
-
10904 Kingston Pike Ste 103
Knoxville, TN 379342953
fax (868) 588-8841 - Additional location
-
501 20Th St Ste 303
Knoxville, TN 379161899
(865) 331-1375
fax (865) 331-1714 - Additional location
-
550 Fort Loudoun Medical Center Dr
Lenoir City, TN 377725673
(865) 271-6000
fax (865) 271-6245 - Additional location
-
744 Middle Creek RD Ste 208
Sevierville, TN 378625036
(865) 446-9725
fax (865) 446-9726 - Additional location
-
8045 Roane Medical Center Dr Ste 240
Harriman, TN 377488333
(865) 316-2876
fax (865) 374-2079 - Additional location
-
9352 Park West Blvd
Knoxville, TN 379234325
(865) 373-1974
fax (865) 373-1059 - Additional location
-
944 Oak Ridge Tpke
Oak Ridge, TN 378306917
(865) 835-3810
fax (865) 835-3811 - Additional location
-
988 Oak Ridge Tpke Ste L20
Oak Ridge, TN 378306944
(865) 444-4321
fax (865) 338-5588
Credentials & registration
- NPI registered
- March 2007 — 19 yrs on file
- Profile last updated
- February 19, 2025
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Tennessee #43458
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477684405. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,208
Distinct HCPCS
10
Medicare allowed
$102,605
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 200 | 90 | $73 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 184 | 104 | $111 | |
99291 |
Critical care, first 30-74 minutes | 132 | 67 | $199 | |
94010 |
Test to measure expiratory airflow and volume | 115 | 115 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 101 | 68 | $117 | |
94010 |
Test to measure expiratory airflow and volume | 68 | 60 | $24 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 62 | 53 | $83 | |
94729 |
Test to examine how well the lungs exchange gases | 44 | 43 | $50 | |
71046 |
X-ray of chest, 2 views | 43 | 37 | $29 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 26 | 26 | $162 |
In context: peer comparison
Among 28 peers in this city , average services per provider: 80. This provider delivers 15× the peer median.Open Payments
Industry payments received
All-time total
$1,352
Transactions
40
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $447.77 | |
| GlaxoSmithKline, LLC. | 10 | $229.57 | |
| Tactile Systems Technology Inc | 1 | $145.63 | |
| GENZYME CORPORATION | 3 | $88.87 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $86.72 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63.64 | |
| Insmed, Inc. | 2 | $59.25 | |
| PFIZER INC. | 2 | $38.22 | |
| Electromed, Inc. | 2 | $37.29 | |
| La Jolla Pharmaceutical Company | 1 | $29.23 | |
| Mylan Specialty L.P. | 1 | $26.47 | |
| Actelion Pharmaceuticals US, Inc. | 1 | $26.02 | |
| ANI Pharmaceuticals, Inc. | 1 | $22.20 | |
| Shionogi Inc | 1 | $18.18 | |
| Philips North America LLC | 1 | $16.55 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
283
Patients
62
Total drug cost
$115,740
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 64 | 17 | $54,541 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 62 | 30 | $1,678 |
| Stiolto Respimat (Tiotropium Br/Olodaterol Hcl) | Brand | 28 | 0 | $15,963 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 20 | 0 | $13,258 |
| Azithromycin | Generic | 19 | 0 | $525 |
| Prednisone | Generic | 15 | 15 | $60 |
| Rifampin | Generic | 15 | 0 | $151 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 13 | 0 | $8,126 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 12 | 0 | $7,481 |
| Eliquis (Apixaban) | Brand | 12 | 0 | $12,063 |
Hospital affiliations
Frequently asked questions
What is Dr. Matthew Reichert's medical specialty?
Dr. Matthew Reichert practices Pulmonary Disease Physician in Knoxville, TN.
Where does Dr. Matthew Reichert practice?
Dr. Matthew Reichert practices at 6473 Kingston Pike, Knoxville, TN 379194832. Office phone: 8655888831.
What is Dr. Matthew Reichert's NPI?
Dr. Matthew Reichert's National Provider Identifier (NPI) is 1477684405, issued by NPPES.
Does Dr. Matthew Reichert accept Medicare assignment?
Yes. Dr. Matthew Reichert accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Reichert commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Critical care (HCPCS 99291). Source: CMS Medicare Physician & Other Practitioners file.